UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The Aurora B kinase activity is required for the maintenance of the differentiated state of murine myoblasts

Cell death and differentiation, 2009-02, Vol.16 (2), p.321-330

2009

Volltextzugriff (PDF)

Induced pluripotent stem cells in hematology: current and future applications

Blood cancer journal (New York), 2014-05, Vol.4 (5), p.e211-e211

2014

Volltextzugriff (PDF)

Compliance and toxicity of adjuvant CMF in elderly breast cancer patients: a single-center experience

BMC cancer, 2005-03, Vol.5 (1), p.30-30, Article 30

2005

Volltextzugriff (PDF)

Is Gemcitabine plus Vinorelbine Active in Second-Line Chemotherapy of Metastatic Breast Cancer? A Single-Center Phase 2 Study

Oncology, 2003-01, Vol.64 (4), p.479-480

2003

Volltextzugriff (PDF)

Mutations of thyrotropin receptor isolated from thyroid autonomous functioning adenomas confer TSH-independent growth to thyroid cells

Oncogene, 1997-08, Vol.15 (7), p.781-789

1997

Volltextzugriff (PDF)

TAZ is required for metastatic activity and chemoresistance of breast cancer stem cells

Oncogene, 2015-02, Vol.34 (6), p.681-690

2015

Volltextzugriff (PDF)

Treatment of Chronic Myelogenous Leukemia by Blocking Cytokine Alterations Found in Normal Stem and Progenitor Cells

Cancer cell, 2015-05, Vol.27 (5), p.671-681

2015

Volltextzugriff (PDF)

Sox4 Is a Key Oncogenic Target in C/EBPα Mutant Acute Myeloid Leukemia

Cancer cell, 2013-11, Vol.24 (5), p.575-588

2013

Volltextzugriff (PDF)

Molecular Remission After Allogeneic or Autologous Transplantation of Hematopoietic Stem Cells for Multiple Myeloma

Journal of clinical oncology, 2000-06, Vol.18 (11), p.2273-2281

2000

Volltextzugriff (PDF)

CD34+ Ph+ cells are still detectable in chronic myeloid leukemia patients with sustained and prolonged complete cytogenetic remission during treatment with imatinib mesylate

Leukemia, 2008-02, Vol.22 (2), p.426-428

2008

Volltextzugriff (PDF)

Prediction of response to imatinib by prospective quantitation of BCR-ABL transcript in late chronic phase chronic myeloid leukemia patients

Annals of oncology, 2006-03, Vol.17 (3), p.495-502

2006

Volltextzugriff (PDF)

The second hit of DNA methylation

Molecular & cellular oncology, 2016-05, Vol.3 (3), p.e1093690-e1093690

2016

Volltextzugriff (PDF)

Sox4 Is a Key Oncogenic Target in C/EBPα Mutant Acute Myeloid Leukemia

Cancer cell, 2014-02, Vol.25 (2), p.257-257

2014

Volltextzugriff (PDF)

Imatinib therapy for chronic myeloid leukemia patients who relapse after allogeneic stem cell transplantation: a molecular analysis

Bone marrow transplantation (Basingstoke), 2007-02, Vol.39 (3), p.189-191

2007

Volltextzugriff (PDF)

Efficacy of imatinib mesylate (STI571) in conjunction with alpha-interferon: long-term quantitative molecular remission in relapsed P-190(BCR-ABL)-positive acute lymphoblastic leukemia

Leukemia, 2002-10, Vol.16 (10), p.2159

2002

Volltextzugriff (PDF)

Nuclear factor-erythroid 2 (NF-E2) expression in normal and malignant megakaryocytopoiesis

Leukemia, 2002-09, Vol.16 (9), p.1773-1781

2002

Volltextzugriff (PDF)

Molecular monitoring of acute myeloid leukemia associated with inv(16): threshold of CBFβ/MYH11 transcript copy number above which relapse occurs and below which continuous Complete Remission is likely

Leukemia, 2003-03, Vol.17 (3), p.650-651

2003

Volltextzugriff (PDF)

Interleukin‐4 Downregulates Nuclear Factor‐Erythroid 2 (NF‐E2) Expression in Primary Megakaryocytes and in Megakaryoblastic Cell Lines

Stem cells (Dayton, Ohio), 2001-01, Vol.19 (4), p.339-347

2001

Volltextzugriff (PDF)

Quantification of BCR-ABL transcripts in CML patients in cytogenetic remission after interferon-α-based therapy

Bone marrow transplantation (Basingstoke), 2000-04, Vol.25 (7), p.729-736

2000

Volltextzugriff (PDF)

Translisin recognition site sequences flank translocation breakpoints in a Philadelphia chromosome positive chronic myeloid leukemia patient expressing a novel type of chimeric BCR-ABL transcript (E8-INT-A2)

Leukemia, 1999-10, Vol.13 (10), p.1635-1637

1999

Volltextzugriff (PDF)

Concomitant expression of the rare E1/A3 and B2/A3 types of BCR/ABL transcript in a chronic myeloid leukemia (CML) patient

Leukemia, 1999-09, Vol.13 (9), p.1463

1999

Volltextzugriff (PDF)

Quantitative Evaluation of BCR-ABL Amount of Transcript Post Mobilization with G-CSF of Peripheral Blood Stem Cells from Chronic Myeloid Leukemia Patients in Cytogenetic Response

Leukemia & lymphoma, 2000-09, Vol.39 (1-2), p.113-120

2000

Volltextzugriff (PDF)

Molecular remission in PCR-positive acute myeloid leukemia patients with inv(16): role of bone marrow transplantation procedures

Bone marrow transplantation (Basingstoke), 1999-09, Vol.24 (6), p.694-697

1999

Volltextzugriff (PDF)

1 – 25 von 30

Suche als RSS-Feed

Aktive Filter

ThemaOncology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(29)
Mit Volltextzugriff
(30)

Publikationsform

Artikel
(30)

Sprache

Englisch
(30)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(29)
Science & Technology
(29)
Humans
(26)
Hematology
(17)
Female
(14)
Middle Aged
(14)
Adult
(12)
Male
(12)
Aged
(8)
Cell Biology
(7)
Leukemia
(7)
Animals
(6)
Benzamides
(6)
Biological And Medical Sciences
(6)
Chronic Myeloid Leukemia
(6)
Fusion Proteins, Bcr-Abl - Genetics
(6)
Imatinib Mesylate
(6)
Leukemia, Myelogenous, Chronic, Bcr-Abl Positive - Drug Therapy
(6)
Pyrimidines - Therapeutic Use
(6)

14 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

The Aurora B kinase activity is required for the maintenance of the differentiated state of murine myoblasts

Induced pluripotent stem cells in hematology: current and future applications

Compliance and toxicity of adjuvant CMF in elderly breast cancer patients: a single-center experience

Is Gemcitabine plus Vinorelbine Active in Second-Line Chemotherapy of Metastatic Breast Cancer? A Single-Center Phase 2 Study

Mutations of thyrotropin receptor isolated from thyroid autonomous functioning adenomas confer TSH-independent growth to thyroid cells

TAZ is required for metastatic activity and chemoresistance of breast cancer stem cells

ABL Mutations in Late Chronic Phase Chronic Myeloid Leukemia Patients With Up-Front Cytogenetic Resistance to Imatinib Are Associated With a Greater Likelihood of Progression to Blast Crisis and Shorter Survival: A Study by the GIMEMA Working Party on Chronic Myeloid Leukemia

Treatment of Chronic Myelogenous Leukemia by Blocking Cytokine Alterations Found in Normal Stem and Progenitor Cells

Sox4 Is a Key Oncogenic Target in C/EBPα Mutant Acute Myeloid Leukemia

Molecular Remission After Allogeneic or Autologous Transplantation of Hematopoietic Stem Cells for Multiple Myeloma

Comparison Between Patients With Philadelphia-Positive Chronic Phase Chronic Myeloid Leukemia Who Obtained a Complete Cytogenetic Response Within 1 Year of Imatinib Therapy and Those Who Achieved Such a Response After 12 Months of Treatment

CD34+ Ph+ cells are still detectable in chronic myeloid leukemia patients with sustained and prolonged complete cytogenetic remission during treatment with imatinib mesylate

Prediction of response to imatinib by prospective quantitation of BCR-ABL transcript in late chronic phase chronic myeloid leukemia patients

The second hit of DNA methylation

Sox4 Is a Key Oncogenic Target in C/EBPα Mutant Acute Myeloid Leukemia

Imatinib therapy for chronic myeloid leukemia patients who relapse after allogeneic stem cell transplantation: a molecular analysis

Efficacy of imatinib mesylate (STI571) in conjunction with alpha-interferon: long-term quantitative molecular remission in relapsed P-190(BCR-ABL)-positive acute lymphoblastic leukemia

Nuclear factor-erythroid 2 (NF-E2) expression in normal and malignant megakaryocytopoiesis

Molecular monitoring of acute myeloid leukemia associated with inv(16): threshold of CBFβ/MYH11 transcript copy number above which relapse occurs and below which continuous Complete Remission is likely

Interleukin‐4 Downregulates Nuclear Factor‐Erythroid 2 (NF‐E2) Expression in Primary Megakaryocytes and in Megakaryoblastic Cell Lines

Quantification of BCR-ABL transcripts in CML patients in cytogenetic remission after interferon-α-based therapy

Translisin recognition site sequences flank translocation breakpoints in a Philadelphia chromosome positive chronic myeloid leukemia patient expressing a novel type of chimeric BCR-ABL transcript (E8-INT-A2)

Concomitant expression of the rare E1/A3 and B2/A3 types of BCR/ABL transcript in a chronic myeloid leukemia (CML) patient

Quantitative Evaluation of BCR-ABL Amount of Transcript Post Mobilization with G-CSF of Peripheral Blood Stem Cells from Chronic Myeloid Leukemia Patients in Cytogenetic Response

Molecular remission in PCR-positive acute myeloid leukemia patients with inv(16): role of bone marrow transplantation procedures

Aktive Filter

Suchergebnisse filtern